×
  • Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Veterinary POC Diagnostic Market

    ID: MRFR/HC/8540-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    Veterinary POC Diagnostic Market Research Report By Product Type (Immunoassays, Sampling Devices, Molecular Diagnostics, Hematology Analyzers), By Technology (Biochemical Analysis, Microbiology Testing, Genetic Testing), By Animal Type (Companion Animals, Livestock, Zoo Animals), By End User (Veterinary Clinics, Research Laboratories, Animal Hospitals) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Veterinary POC Diagnostic Market Infographic
    Purchase Options

    Veterinary POC Diagnostic Market Summary

    As per MRFR analysis, the Veterinary POC Diagnostic Market was estimated at 2.468 USD Billion in 2024. The Veterinary POC Diagnostic industry is projected to grow from 2.66 USD Billion in 2025 to 5.627 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.78 during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The Veterinary POC Diagnostic Market is experiencing robust growth driven by technological advancements and an increasing focus on preventive care.

    • North America remains the largest market for veterinary POC diagnostics, driven by high pet ownership rates and advanced healthcare infrastructure.
    • The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising disposable incomes and increasing awareness of animal health.
    • Immunoassays dominate the market as the largest segment, while molecular diagnostics are rapidly gaining traction as the fastest-growing segment.
    • Key market drivers include technological advancements in diagnostics and a rising demand for zoonotic disease testing, reflecting a shift towards preventive care.

    Market Size & Forecast

    2024 Market Size 2.468 (USD Billion)
    2035 Market Size 5.627 (USD Billion)
    CAGR (2025 - 2035) 7.78%

    Major Players

    Idexx Laboratories (US), Zoetis (US), Thermo Fisher Scientific (US), Heska Corporation (US), Neogen Corporation (US), Virbac (FR), Boehringer Ingelheim (DE), Randox Laboratories (GB), EIKEN Chemical (JP)

    Veterinary POC Diagnostic Market Trends

    The Veterinary POC Diagnostic Market is currently experiencing a notable transformation, driven by advancements in technology and an increasing emphasis on rapid diagnostics. This market encompasses a range of point-of-care testing solutions that facilitate immediate results for various veterinary conditions. The growing awareness of animal health and welfare, coupled with the rising demand for efficient diagnostic tools, appears to be propelling the market forward. Furthermore, the integration of innovative technologies, such as mobile applications and cloud-based data management, seems to enhance the accessibility and usability of these diagnostic devices. In addition, the Veterinary POC Diagnostic Market is likely to benefit from the increasing prevalence of zoonotic diseases and the need for timely interventions. Veterinary professionals are increasingly seeking tools that provide quick and accurate results, which may lead to improved treatment outcomes. The trend towards preventive care and routine health monitoring in pets and livestock is also influencing the market landscape. As stakeholders continue to prioritize animal health, the Veterinary POC Diagnostic Market is poised for sustained growth, reflecting a broader commitment to enhancing veterinary care and ensuring the well-being of animals across various settings.

    Technological Advancements

    The Veterinary POC Diagnostic Market is witnessing a surge in technological innovations, which are enhancing the capabilities of diagnostic tools. These advancements include the development of portable devices that offer rapid testing and results, thereby streamlining the diagnostic process. Such innovations are likely to improve the efficiency of veterinary practices and facilitate better decision-making.

    Increased Focus on Preventive Care

    There is a growing trend towards preventive care within the Veterinary POC Diagnostic Market, as veterinarians and pet owners alike recognize the importance of early detection of health issues. This shift is encouraging the adoption of diagnostic tools that enable routine health monitoring, ultimately leading to improved animal welfare and reduced healthcare costs.

    Rising Demand for Zoonotic Disease Testing

    The Veterinary POC Diagnostic Market is experiencing an increased demand for testing solutions related to zoonotic diseases. As awareness of the transmission of diseases from animals to humans rises, veterinary professionals are prioritizing diagnostics that can quickly identify potential health threats. This trend underscores the importance of timely interventions in safeguarding both animal and human health.

    Veterinary POC Diagnostic Market Drivers

    Regulatory Support and Standards

    Regulatory support plays a crucial role in shaping the Veterinary POC Diagnostic Market. Governments and regulatory bodies are increasingly establishing standards and guidelines that facilitate the development and approval of veterinary diagnostic products. This support not only ensures the safety and efficacy of diagnostic tools but also encourages innovation within the industry. As regulatory frameworks become more favorable, manufacturers are likely to invest in research and development, leading to the introduction of new and improved diagnostic solutions. This regulatory environment is expected to positively influence the growth trajectory of the Veterinary POC Diagnostic Market.

    Growing Pet Ownership and Spending

    The Veterinary POC Diagnostic Market is significantly influenced by the growing trend of pet ownership and increased spending on pet care. As more households adopt pets, there is a corresponding rise in demand for veterinary services, including diagnostics. Pet owners are increasingly willing to invest in their pets' health, leading to higher expenditures on veterinary care. This trend is reflected in the projected growth of the veterinary diagnostics market, which is anticipated to reach USD 3.5 billion by 2026. The increasing focus on pet health and wellness is likely to drive the expansion of the Veterinary POC Diagnostic Market.

    Increased Focus on Preventive Care

    There is a notable shift towards preventive care within the Veterinary POC Diagnostic Market. Pet owners and veterinarians are increasingly recognizing the importance of early detection of diseases to ensure better health outcomes for animals. This trend is reflected in the rising demand for routine diagnostic tests, which are essential for monitoring the health of pets. The market is expected to grow as more veterinary practices adopt preventive care protocols, leading to an increase in the utilization of point-of-care diagnostics. This proactive approach not only enhances animal welfare but also contributes to the overall growth of the Veterinary POC Diagnostic Market.

    Technological Advancements in Diagnostics

    The Veterinary POC Diagnostic Market is experiencing a surge in technological advancements that enhance diagnostic capabilities. Innovations such as portable diagnostic devices and rapid testing kits are becoming increasingly prevalent. These technologies allow for immediate results, which is crucial in veterinary practices where timely decisions can significantly impact animal health. The market for veterinary diagnostics is projected to reach USD 3.5 billion by 2026, driven by these advancements. Furthermore, the integration of artificial intelligence and machine learning into diagnostic tools is expected to improve accuracy and efficiency, thereby fostering growth in the Veterinary POC Diagnostic Market.

    Rising Demand for Zoonotic Disease Testing

    The Veterinary POC Diagnostic Market is witnessing a rising demand for testing related to zoonotic diseases. As awareness of the transmission of diseases from animals to humans increases, there is a growing need for rapid and accurate diagnostic tools. This demand is particularly evident in regions where zoonotic diseases are prevalent, prompting veterinarians to utilize point-of-care diagnostics for timely identification and management. The market for zoonotic disease testing is projected to expand, driven by the need for effective surveillance and control measures. Consequently, this trend is likely to bolster the Veterinary POC Diagnostic Market.

    Market Segment Insights

    By Product Type: Immunoassays (Largest) vs. Molecular Diagnostics (Fastest-Growing)

    In the Veterinary POC Diagnostic Market, the distribution of market share among product types reveals a pronounced dominance of immunoassays, which continue to capture the largest segment of the market. Their established usage in rapid disease detection and ease of integration into veterinary practice contribute to this leading position. Following immunoassays, molecular diagnostics emerge as a significant player, showcasing notable growth potential as diagnostic technologies evolve and practices seek more accurate pathogen identification.

    Immunoassays (Dominant) vs. Molecular Diagnostics (Emerging)

    Immunoassays stand as the dominant technology in the Veterinary POC Diagnostic Market, celebrated for their rapid results and reliability in diagnosing infectious diseases. The ease of use and minimal training required for operators make immunoassays a staple in veterinary clinics. In contrast, molecular diagnostics represent an emerging technology trend, gaining traction due to advancements in techniques such as PCR and next-generation sequencing. Though currently smaller in market share, molecular diagnostics are poised for accelerated growth, driven by the demand for precise and rapid testing solutions. As veterinary professionals increasingly adopt these technologies, the competitive landscape is bound to shift, highlighting the importance of both segments in shaping the future of veterinary diagnostics.

    By Technology: Biochemical Analysis (Largest) vs. Microbiology Testing (Fastest-Growing)

    In the Veterinary POC Diagnostic Market, Biochemical Analysis holds the largest share owing to its widespread application in routine diagnostics for various conditions in animals. This segment is essential for evaluating metabolic disorders, organ function, and overall health, making it a foundational aspect of veterinary diagnostics. On the other hand, Microbiology Testing is identified as the fastest-growing segment in the market. The increasing prevalence of infectious diseases and the growing demand for rapid point-of-care testing methods have propelled its growth. The need for timely diagnostics to make informed treatment decisions is a significant driver for this segment's expansion.

    Technology: Biochemical Analysis (Dominant) vs. Microbiology Testing (Emerging)

    Biochemical Analysis stands as the dominant technology in the Veterinary POC Diagnostic Market, characterized by its ability to provide critical information on animal health rapidly. It encompasses various assays that monitor crucial biochemical parameters like glucose, protein, and electrolyte levels, which are foundational for timely veterinary care. In contrast, Microbiology Testing, while emerging, plays a crucial role in diagnosing infections and guiding treatment protocols against pathogens. Its rapid growth is driven by advancements in testing technologies and increasing awareness of infectious diseases in animals, making it essential for ensuring the health and well-being of veterinary patients.

    By Animal Type: Companion Animals (Largest) vs. Livestock (Fastest-Growing)

    The Veterinary POC Diagnostic Market is predominantly driven by the Companion Animals segment, which holds the largest share. This segment's growth is attributed to the increasing pet ownership rates and the rising awareness among pet owners about the importance of regular health check-ups. Meanwhile, the Livestock segment is gaining traction as the fastest-growing category, fueled by the demand for advanced diagnostic solutions in agricultural practices and the need for optimizing livestock health management.

    Companion Animals (Dominant) vs. Livestock (Emerging)

    The Companion Animals segment is the dominant player in the Veterinary POC Diagnostic Market, characterized by a broad range of diagnostic tests designed for pets such as dogs and cats. This segment is supported by a growing trend in pet humanization, leading to increased spending on pet healthcare and diagnostics. On the other hand, the Livestock segment is emerging as a significant focus due to the increasing need for monitoring health in cattle, pigs, and poultry. The demand for rapid and accurate diagnostics in livestock farming is driven by the necessity to enhance productivity and manage diseases effectively, making it a pivotal area of growth within the market.

    By End User: Veterinary Clinics (Largest) vs. Animal Hospitals (Fastest-Growing)

    The Veterinary POC Diagnostic Market is witnessing a strategic distribution of market share across its primary end-user segments, which include Veterinary Clinics, Research Laboratories, and Animal Hospitals. Veterinary Clinics represent the largest share, primarily due to the higher frequency of tests and diagnostics performed within these facilities. In comparison, Research Laboratories are crucial for innovation and advancements, but they account for a smaller portion of the market, as they are not as widely utilized as veterinary clinics and animal hospitals. Animal Hospitals are emerging as the fastest-growing segment within this market, driven by an increasing demand for immediate diagnostic tests and the rising need for urgent care. The growing pet ownership and heightened awareness regarding animal health are key factors propelling this trend. Furthermore, advancements in POC diagnostic technologies are enhancing the capabilities of animal hospitals, enabling them to provide rapid and accurate testing, thereby supporting their expansion in the market.

    Veterinary Clinics (Dominant) vs. Research Laboratories (Emerging)

    Veterinary Clinics hold a dominant position in the Veterinary POC Diagnostic Market, primarily due to their extensive daily interactions with pet owners and the continuous requirement for diagnostic testing. They typically employ a variety of point-of-care devices to efficiently diagnose common ailments, thus promoting quicker treatment and improving patient outcomes. On the other hand, Research Laboratories, while considered an emerging segment, play a vital role in the development and validation of new diagnostic tools and technologies. They focus on innovative research, which ultimately aids in advancing the capabilities of veterinary diagnostics. As these laboratories evolve, they are increasingly becoming influential in determining future market trends, especially in terms of introducing cutting-edge diagnostic solutions.

    Get more detailed insights about Veterinary POC Diagnostic Market

    Regional Insights

    The Veterinary POC Diagnostic Market revenue showcases a clear regional layout, with North America holding a prominent position, recording a value of 1.1 USD Billion in 2023 and projected to reach 2.2 USD Billion by 2032. This dominance is primarily driven by advanced veterinary infrastructure and heightened awareness regarding animal health. Europe follows, exhibiting a significant valuation of 0.8 USD Billion in 2023, expected to attain 1.7 USD Billion by 2032, highlighting strong veterinary practices and increasing pet ownership.

    The APAC region, while smaller, demonstrates potential with a market value of 0.25 USD Billion in 2023, anticipated to expand to 0.55 USD Billion by 2032, as emerging economies invest more in veterinary care. South America and MEA exhibit smaller shares, with valuations of 0.07 USD Billion each in 2023, growing to 0.12 USD Billion and 0.13 USD Billion, respectively, by 2032. These regions face challenges in veterinary services but present opportunities for growth driven by increased animal husbandry practices and awareness.

    Overall, the Veterinary POC Diagnostic Market segmentation reveals diverse contributions from each region, underscoring varied growth dynamics and potential across the landscape.

    Veterinary POC Diagnostic Market Regional Insights

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The Veterinary Point-of-Care (POC) Diagnostic Market is rapidly evolving, fueled by the increasing demand for rapid, accurate diagnostic solutions that facilitate timely decision-making in veterinary practices. This dynamic market encompasses various diagnostic tests and devices specifically designed to provide immediate results for veterinary professionals. The competitive landscape is characterized by a mix of established players and innovative newcomers, all striving to enhance their product offerings through technological advancements and expanding their market presence. Factors such as the rising prevalence of zoonotic diseases, growing pet ownership, and the increasing need for preventative healthcare in animals are propelling the market forward.

    Companies are focusing on strategic collaborations, mergers, and acquisitions to leverage their strengths and expand their footprint in emerging markets, thereby offering enhanced diagnostic solutions tailored to veterinarians' needs. Randox Laboratories has established itself as a leading player in the Veterinary POC Diagnostic Market, primarily due to its commitment to innovation and quality.

    The company offers a diverse portfolio of diagnostic solutions, including advanced testing platforms that cater specifically to veterinary practices. Randox Laboratories' strengths lie in its ability to provide rapid, reliable results across a wide range of veterinary conditions. Furthermore, the company has invested significantly in research and development, allowing it to stay ahead of industry trends and meet the evolving needs of its customers. With a strong emphasis on customer support and training, Randox Laboratories has built a solid reputation among veterinary professionals, enhancing its competitive edge and market presence.

    Neogen Corporation is another prominent player in the Veterinary POC Diagnostic Market, recognized for its dedication to providing effective diagnostic solutions for animal health. Known for its strong focus on food and animal safety, Neogen Corporation offers a range of innovative products tailored to the veterinary sector.

    The company has successfully developed and marketed POC diagnostic tests that are easy to use and deliver rapid results, making them highly preferable for veterinarians in various practice settings. Neogen Corporation's strengths are rooted in its broad distribution network and its ability to adapt to the ever-changing demands of the veterinary market. By leveraging its extensive research capabilities and commitment to quality, Neogen Corporation continues to solidify its presence and influence in the veterinary diagnostics landscape, making it a key player in the competitive environment of the Veterinary POC Diagnostic Market.

    Key Companies in the Veterinary POC Diagnostic Market market include

    Industry Developments

    • Q2 2024: IDEXX Launches ProCyte One Hematology Analyzer for Veterinary Clinics IDEXX Laboratories announced the commercial launch of the ProCyte One Hematology Analyzer, a new point-of-care device designed to deliver rapid and accurate blood analysis for veterinary practices.
    • Q2 2024: Zoetis Receives CE Mark for Vetscan Imagyst Rapid Diagnostic Platform in Europe Zoetis announced it has received CE Mark approval for its Vetscan Imagyst platform, enabling the rapid deployment of its AI-powered point-of-care diagnostic solution for veterinary clinics across the European Union.
    • Q3 2024: Heska Expands Global Footprint with New Diagnostic Manufacturing Facility in Germany Heska Corporation opened a new manufacturing facility in Germany dedicated to the production of advanced point-of-care diagnostic devices for veterinary use, aiming to meet growing demand in the EMEA region.
    • Q1 2024: Antech Diagnostics Acquires UK-based POC Vet Diagnostics Startup Antech Diagnostics, a Mars Petcare company, announced the acquisition of a UK-based startup specializing in rapid point-of-care diagnostic tests for companion animals, strengthening its European market presence.
    • Q2 2024: Zoetis Announces Strategic Partnership with Mindray for Veterinary POC Devices Zoetis entered into a strategic partnership with Mindray to co-develop and distribute new point-of-care diagnostic devices for veterinary clinics, targeting both North American and Asia-Pacific markets.
    • Q2 2024: IDEXX Laboratories Appoints New Chief Technology Officer to Lead Diagnostic Innovation IDEXX Laboratories named Dr. Emily Chen as Chief Technology Officer, tasking her with accelerating the development of next-generation point-of-care diagnostic solutions for the veterinary sector.
    • Q3 2024: Zoetis Launches Vetscan Flex Rapid Test for Canine Parvovirus Zoetis introduced the Vetscan Flex Rapid Test, a new point-of-care diagnostic kit for the detection of canine parvovirus, expanding its suite of rapid veterinary diagnostics.
    • Q1 2025: IDEXX Receives FDA Clearance for SNAP Heartworm RT Test for Dogs IDEXX Laboratories announced it has received FDA clearance for its SNAP Heartworm RT Test, a rapid point-of-care diagnostic for canine heartworm disease, enabling broader clinical adoption in the U.S.
    • Q2 2025: Heska Secures Multi-Year Contract with Major U.S. Veterinary Chain for POC Diagnostics Heska Corporation signed a multi-year supply agreement with a leading U.S. veterinary clinic chain to provide point-of-care diagnostic equipment and consumables.
    • Q2 2025: Zoetis Launches Vetscan Imagyst Fecal Egg Count Test in Australia Zoetis expanded its Vetscan Imagyst platform with the launch of a new Fecal Egg Count Test for livestock in Australia, providing rapid, on-site parasite diagnostics for veterinarians and farmers.
    • Q3 2025: IDEXX Laboratories Acquires AI Diagnostics Startup to Enhance POC Offerings IDEXX Laboratories acquired a U.S.-based artificial intelligence diagnostics startup, aiming to integrate advanced AI capabilities into its point-of-care veterinary diagnostic platforms.
    • Q1 2025: FUJIFILM Europe Launches VETSCAN VUE Analyzer for Veterinary Clinics FUJIFILM Europe announced the launch of the VETSCAN VUE Analyzer, a new point-of-care diagnostic device designed for rapid in-clinic testing of multiple animal diseases.

    Future Outlook

    Veterinary POC Diagnostic Market Future Outlook

    The Veterinary POC Diagnostic Market is projected to grow at a 7.78% CAGR from 2024 to 2035, driven by technological advancements, increasing pet ownership, and demand for rapid diagnostics.

    New opportunities lie in:

    • Development of portable diagnostic devices for remote veterinary practices.
    • Integration of AI-driven analytics for enhanced diagnostic accuracy.
    • Expansion of telemedicine platforms for real-time diagnostic consultations.

    By 2035, the market is expected to be robust, reflecting substantial growth and innovation.

    Market Segmentation

    Veterinary POC Diagnostic Market End User Outlook

    • Veterinary Clinics
    • Research Laboratories
    • Animal Hospitals

    Veterinary POC Diagnostic Market Technology Outlook

    • Biochemical Analysis
    • Microbiology Testing
    • Genetic Testing

    Veterinary POC Diagnostic Market Animal Type Outlook

    • Companion Animals
    • Livestock
    • Zoo Animals

    Veterinary POC Diagnostic Market Product Type Outlook

    • Immunoassays
    • Sampling Devices
    • Molecular Diagnostics
    • Hematology Analyzers

    Report Scope

    MARKET SIZE 20242.468(USD Billion)
    MARKET SIZE 20252.66(USD Billion)
    MARKET SIZE 20355.627(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)7.78% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledMarket analysis in progress
    Segments CoveredMarket segmentation analysis in progress
    Key Market OpportunitiesIntegration of advanced technologies enhances rapid diagnostics in the Veterinary POC Diagnostic Market.
    Key Market DynamicsRising demand for rapid diagnostics drives innovation and competition in the Veterinary Point-of-Care Diagnostic Market.
    Countries CoveredNorth America, Europe, APAC, South America, MEA

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the projected market size of the Veterinary POC Diagnostic Market by 2035?

    The Veterinary POC Diagnostic Market is expected to reach a value of 5.63 USD Billion by 2035.

    What is the expected CAGR for the Veterinary POC Diagnostic Market from 2024 to 2032?

    The market is anticipated to grow at a CAGR of 7.91% from 2024 to 2035.

    Which region holds the largest market share in the Veterinary POC Diagnostic Market in 2023?

    North America is expected to hold the largest market share, valued at 1.1 USD Billion in 2023.

    What will be the market value of Immunoassays in the Veterinary POC Diagnostic Market by 2035?

    Immunoassays are projected to have a market value of 5.63 USD Billion by 2035.

    Can you name some major players in the Veterinary POC Diagnostic Market?

    Key players in the market include Randox Laboratories, Neogen Corporation, IDEXX Laboratories, and Zoetis.

    What is the expected market size for Molecular Diagnostics in 2035?

    Molecular Diagnostics is expected to reach a market size of 1.2 USD Billion by 2035.

    What is the projected growth of the APAC region within the Veterinary POC Diagnostic Market by 2032?

    The APAC region is anticipated to grow to a market size of 0.55 USD Billion by 2035.

    What will be the market value of the Sampling Devices segment by 2032?

    The market value for Sampling Devices is projected to be 1.0 USD Billion by 2035.

    What challenges does the Veterinary POC Diagnostic Market face?

    Challenges include the high costs of advanced diagnostic equipment and regulatory hurdles.

    What market value is projected for Hematology Analyzers by 2032?

    Hematology Analyzers are expected to reach a market value of 0.7 USD Billion by 2035.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions